Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001415889-25-013620

Director bought 2,520 shares at $13.62 ($34,317)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Heron Patrick J Director 2025-05-15 Purchase +2,520 $13.62 $34,317 17,494 I: show line 1 in the form
Open-market purchases · 2,520 sh · avg $13.62 · $34,317
Loading xslF345X05/form4-05192025_080553.xml…